demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
non-steroidal anti-inflammatory drugs Guzman-Esquivel
Indomethacin Ravichandran

6 studies excluded by filtering options 1

5423 Jeong, 2020 1150not a RCTrisk of bias not avaialble
5764 Wenxin, 2020 1100not a RCTrisk of bias not avaialble
6188 Bruce, 2020 1100not a RCTrisk of bias not avaialble
6361 Ravichandran, 2020 1100not a RCTrisk of bias not avaialble
6960 Imam, 2020 1130not a RCTrisk of bias not avaialble
7011 Drake, 2021 1100not a RCTrisk of bias not avaialble